Trial Profile
The Effect of Botulinum Toxin A (BOTOX®) on Headache Attributed to TMD - An Open Label Trial
Status:
Completed
Phase of Trial:
Phase 0
Latest Information Update: 06 Oct 2022
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Secondary headache disorders
- Focus Therapeutic Use
- 30 Sep 2022 Status changed from recruiting to completed.
- 20 Nov 2017 New trial record